Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.
Br J Pharmacol. 2011 Apr;162(8):1819-31. doi: 10.1111/j.1476-5381.2011.01203.x.
Exposure to mercury is known to increase cardiovascular risk but the underlying mechanisms are not well explored. We analysed whether chronic exposure to low mercury doses affects endothelial modulation of the coronary circulation.
Left coronary arteries and hearts from Wistar rats treated with either HgCl(2) (first dose 4.6 µg·kg(-1) , subsequent doses 0.07 µg·kg(-1) day(-1) , 30 days) or vehicle were used. Endothelial cells from pig coronary arteries incubated with HgCl(2) were also used.
Mercury treatment increased 5-HT-induced vasoconstriction but reduced acetylcholine-induced vasodilatation. It also reduced nitric oxide (NO) production and the effects of NO synthase inhibition with L-NAME (100 µmol·L(-1) ) on 5-HT and acetylcholine responses. Superoxide anion production and mRNA levels of NOX-1 and NOX-4 were all increased. The superoxide anion scavenger tiron (1 mmol·L(-1)) reduced 5-HT responses and increased acetylcholine responses only in vessels from mercury-treated rats. In isolated hearts from mercury-treated rats, coronary perfusion and diastolic pressure were unchanged, but developed isovolumetric systolic pressure was reduced. In these hearts, L-NAME increased coronary perfusion pressure and diastolic pressure while it further reduced developed systolic pressure.
Chronic exposure to low doses of mercury promotes endothelial dysfunction of coronary arteries, as shown by decreased NO bioavailability induced by increased oxidative stress. These effects on coronary function increase resistance to flow, which under overload conditions might cause ventricular contraction and relaxation impairment. These findings provide further evidence that mercury, even at low doses, could be an environmental risk factor for cardiovascular disease.
已知汞暴露会增加心血管风险,但潜在机制尚未得到充分探索。我们分析了慢性低剂量汞暴露是否会影响冠状动脉循环的内皮调节。
使用经 HgCl₂(第一剂量 4.6 µg·kg⁻¹,随后剂量 0.07 µg·kg⁻¹·天⁻¹,30 天)或载体处理的 Wistar 大鼠的左冠状动脉和心脏,以及用 HgCl₂孵育的猪冠状动脉内皮细胞。
汞处理增加了 5-HT 诱导的血管收缩,但减少了乙酰胆碱诱导的血管舒张。它还降低了一氧化氮(NO)的产生,以及用 L-NAME(100 µmol·L⁻¹)抑制 NO 合酶对 5-HT 和乙酰胆碱反应的影响。超氧化物阴离子的产生和 NOX-1 和 NOX-4 的 mRNA 水平均增加。超氧化物阴离子清除剂 tiron(1 mmol·L⁻¹)减少了仅在汞处理大鼠血管中的 5-HT 反应,并增加了乙酰胆碱反应。在汞处理大鼠的离体心脏中,冠状动脉灌注和舒张压不变,但等容收缩压降低。在这些心脏中,L-NAME 增加了冠状动脉灌注压和舒张压,同时进一步降低了收缩压。
慢性低剂量汞暴露会促进冠状动脉内皮功能障碍,表现为氧化应激增加导致的 NO 生物利用度降低。这些对冠状动脉功能的影响增加了血流阻力,在超负荷条件下可能导致心室收缩和舒张功能障碍。这些发现进一步证明,即使在低剂量下,汞也可能成为心血管疾病的环境风险因素。